Anti-CD20 monoclonal antibody (Rituximab) treatment for Epstein-Barr virus-associated, B-cell lymphoproliferative disease in pediatric liver transplant recipients.

Source:http://linkedlifedata.com/resource/pubmed/id/11930095

Download in:

View as

General Info

PMID
11930095